3. GOOD HEALTH AND WELL-BEING

Virginia Retirement Systems ET AL Acquires 700 Shares of Guardant Health, Inc. (NASDAQ:GH) – Defense World

Written by Amanda

Virginia Retirement Systems ET AL Acquires 700 Shares of Guardant Health, Inc. (NASDAQ:GH)  Defense World

Virginia Retirement Systems ET AL lifted its holdings in Guardant Health, Inc. (NASDAQ:GHGet Rating) by 6.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,200 shares of the company’s stock after buying an additional 700 shares during the period. Virginia Retirement Systems ET AL’s holdings in Guardant Health were worth $808,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. Capital Research Global Investors grew its holdings in Guardant Health by 50.0% during the 4th quarter. Capital Research Global Investors now owns 7,927,702 shares of the company’s stock valued at $792,929,000 after purchasing an additional 2,640,910 shares during the last quarter. Capital International Investors grew its holdings in Guardant Health by 38.0% during the 4th quarter. Capital International Investors now owns 2,971,384 shares of the company’s stock valued at $297,198,000 after purchasing an additional 818,309 shares during the last quarter. Casdin Capital LLC bought a new position in Guardant Health during the 4th quarter valued at about $79,016,000. D1 Capital Partners L.P. bought a new position in Guardant Health during the 4th quarter valued at about $47,867,000. Finally, American Century Companies Inc. grew its holdings in Guardant Health by 56.2% during the 4th quarter. American Century Companies Inc. now owns 1,005,098 shares of the company’s stock valued at $100,530,000 after purchasing an additional 361,498 shares during the last quarter. Hedge funds and other institutional investors own 93.69% of the company’s stock.

Shares of GH opened at $50.39 on Friday. The company has a 50 day moving average price of $40.60 and a 200-day moving average price of $60.63. Guardant Health, Inc. has a fifty-two week low of $27.65 and a fifty-two week high of $133.82. The stock has a market capitalization of $5.14 billion, a PE ratio of -12.23 and a beta of 0.71. The company has a debt-to-equity ratio of 2.13, a quick ratio of 4.71 and a current ratio of 4.87.

Guardant Health (NASDAQ:GHGet Rating) last announced its quarterly earnings results on Thursday, May 5th. The company reported ($1.21) earnings per share for the quarter, topping the consensus estimate of ($1.23) by $0.02. Guardant Health had a negative net margin of 107.20% and a negative return on equity of 62.68%. The firm had revenue of $96.10 million during the quarter, compared to analysts’ expectations of $95.71 million. During the same quarter in the prior year, the company earned ($1.06) EPS. The company’s revenue was up 22.2% compared to the same quarter last year. Equities research analysts forecast that Guardant Health, Inc. will post -4.75 EPS for the current year.

A number of equities analysts have commented on GH shares. Citigroup dropped their target price on shares of Guardant Health from $120.00 to $100.00 in a research note on Friday, May 6th. Piper Sandler started coverage on shares of Guardant Health in a research note on Thursday, June 2nd. They issued an “overweight” rating and a $65.00 target price on the stock. Eleven research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $131.73.

About Guardant Health (Get Rating)

Guardant Health, Inc, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients.

Featured Stories

Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health, Inc. (NASDAQ:GHGet Rating).

Institutional Ownership by Quarter for Guardant Health (NASDAQ:GH)

Receive News & Ratings for Guardant Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Guardant Health and related companies with MarketBeat.com’s FREE daily email newsletter.

Source: defenseworld.net

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai

Leave a Comment